These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Inhibition of RhoA/ROCK signaling pathway ameliorates hypoxic pulmonary hypertension via HIF-1α-dependent functional TRPC channels. Wang XY; Mo D; Tian W; Liu XX; Zhou YG; Sun Y; Feng YD; Xiao X; Hao XW; Zhang HN; Li C; Cao W; Li XQ Toxicol Appl Pharmacol; 2019 Apr; 369():60-72. PubMed ID: 30831131 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of the Rho/ROCK pathway enhances the efficacy of cisplatin through the blockage of hypoxia-inducible factor-1α in human ovarian cancer cells. Ohta T; Takahashi T; Shibuya T; Amita M; Henmi N; Takahashi K; Kurachi H Cancer Biol Ther; 2012 Jan; 13(1):25-33. PubMed ID: 22336585 [TBL] [Abstract][Full Text] [Related]
4. MFTZ-1 reduces constitutive and inducible HIF-1α accumulation and VEGF secretion independent of its topoisomerase II inhibition. Dai M; Miao ZH; Ren X; Tong LJ; Yang N; Li T; Lin LP; Shen YM; Ding J J Cell Mol Med; 2010 Sep; 14(9):2281-91. PubMed ID: 19538463 [TBL] [Abstract][Full Text] [Related]
5. Magnolol suppresses hypoxia-induced angiogenesis via inhibition of HIF-1α/VEGF signaling pathway in human bladder cancer cells. Chen MC; Lee CF; Huang WH; Chou TC Biochem Pharmacol; 2013 May; 85(9):1278-87. PubMed ID: 23416116 [TBL] [Abstract][Full Text] [Related]
6. Rhapontigenin inhibited hypoxia inducible factor 1 alpha accumulation and angiogenesis in hypoxic PC-3 prostate cancer cells. Jung DB; Lee HJ; Jeong SJ; Lee HJ; Lee EO; Kim YC; Ahn KS; Chen CY; Kim SH Biol Pharm Bull; 2011; 34(6):850-5. PubMed ID: 21628883 [TBL] [Abstract][Full Text] [Related]
7. Hypoxia effects on proangiogenic factors in human umbilical vein endothelial cells: functional role of the peptide somatostatin. Dal Monte M; Martini D; Ristori C; Azara D; Armani C; Balbarini A; Bagnoli P Naunyn Schmiedebergs Arch Pharmacol; 2011 Jun; 383(6):593-612. PubMed ID: 21523559 [TBL] [Abstract][Full Text] [Related]
8. Fasudil inhibits vascular endothelial growth factor-induced angiogenesis in vitro and in vivo. Yin L; Morishige K; Takahashi T; Hashimoto K; Ogata S; Tsutsumi S; Takata K; Ohta T; Kawagoe J; Takahashi K; Kurachi H Mol Cancer Ther; 2007 May; 6(5):1517-25. PubMed ID: 17513600 [TBL] [Abstract][Full Text] [Related]
9. A hypoxia-driven vascular endothelial growth factor/Flt1 autocrine loop interacts with hypoxia-inducible factor-1alpha through mitogen-activated protein kinase/extracellular signal-regulated kinase 1/2 pathway in neuroblastoma. Das B; Yeger H; Tsuchida R; Torkin R; Gee MF; Thorner PS; Shibuya M; Malkin D; Baruchel S Cancer Res; 2005 Aug; 65(16):7267-75. PubMed ID: 16103078 [TBL] [Abstract][Full Text] [Related]
10. Loss of HIF-1alpha in endothelial cells disrupts a hypoxia-driven VEGF autocrine loop necessary for tumorigenesis. Tang N; Wang L; Esko J; Giordano FJ; Huang Y; Gerber HP; Ferrara N; Johnson RS Cancer Cell; 2004 Nov; 6(5):485-95. PubMed ID: 15542432 [TBL] [Abstract][Full Text] [Related]
12. GDF-15 promotes angiogenesis through modulating p53/HIF-1α signaling pathway in hypoxic human umbilical vein endothelial cells. Song H; Yin D; Liu Z Mol Biol Rep; 2012 Apr; 39(4):4017-22. PubMed ID: 21773947 [TBL] [Abstract][Full Text] [Related]
13. Stathmin, a microtubule regulatory protein, is associated with hypoxia-inducible factor-1alpha levels in human endometrial and endothelial cells. Yoshie M; Miyajima E; Kyo S; Tamura K Endocrinology; 2009 May; 150(5):2413-8. PubMed ID: 19179443 [TBL] [Abstract][Full Text] [Related]
14. Aspirin Affects Tumor Angiogenesis and Sensitizes Human Glioblastoma Endothelial Cells to Temozolomide, Bevacizumab, and Sunitinib, Impairing Vascular Endothelial Growth Factor-Related Signaling. Navone SE; Guarnaccia L; Cordiglieri C; Crisà FM; Caroli M; Locatelli M; Schisano L; Rampini P; Miozzo M; La Verde N; Riboni L; Campanella R; Marfia G World Neurosurg; 2018 Dec; 120():e380-e391. PubMed ID: 30144594 [TBL] [Abstract][Full Text] [Related]
15. ATF4 promotes bone angiogenesis by increasing VEGF expression and release in the bone environment. Zhu K; Jiao H; Li S; Cao H; Galson DL; Zhao Z; Zhao X; Lai Y; Fan J; Im HJ; Chen D; Xiao G J Bone Miner Res; 2013 Sep; 28(9):1870-1884. PubMed ID: 23649506 [TBL] [Abstract][Full Text] [Related]
16. Rho-kinase inhibition prevents the progression of diabetic nephropathy by downregulating hypoxia-inducible factor 1α. Matoba K; Kawanami D; Okada R; Tsukamoto M; Kinoshita J; Ito T; Ishizawa S; Kanazawa Y; Yokota T; Murai N; Matsufuji S; Takahashi-Fujigasaki J; Utsunomiya K Kidney Int; 2013 Sep; 84(3):545-54. PubMed ID: 23615507 [TBL] [Abstract][Full Text] [Related]
17. Hypoxia inducible factor-1α/vascular endothelial growth factor signaling activation correlates with response to radiotherapy and its inhibition reduces hypoxia-induced angiogenesis in lung cancer. Zhu H; Zhang S J Cell Biochem; 2018 Sep; 119(9):7707-7718. PubMed ID: 29904944 [TBL] [Abstract][Full Text] [Related]
18. Steppogenin suppresses tumor growth and sprouting angiogenesis through inhibition of HIF-1α in tumors and DLL4 activity in the endothelium. Cha S; Kim HG; Jang H; Lee J; Chao T; Baek NI; Song IS; Lee YM Phytomedicine; 2023 Jan; 108():154513. PubMed ID: 36332389 [TBL] [Abstract][Full Text] [Related]
19. Antiangiogenic properties of fasudil, a potent Rho-Kinase inhibitor. Hata Y; Miura M; Nakao S; Kawahara S; Kita T; Ishibashi T Jpn J Ophthalmol; 2008; 52(1):16-23. PubMed ID: 18369695 [TBL] [Abstract][Full Text] [Related]
20. Adrenomedullin promotes angiogenesis in epithelial ovarian cancer through upregulating hypoxia-inducible factor-1α and vascular endothelial growth factor. Zhang Y; Xu Y; Ma J; Pang X; Dong M Sci Rep; 2017 Jan; 7():40524. PubMed ID: 28091613 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]